Our Entrepreneurs

Christopher Whitfield

Batswadi Pharmaceuticals

Christopher Whitfield Christopher Whitfield
“I saw an opportunity to transform the pharmaceutical industry in South Africa.”
Country
South Africa
Industry
Healthcare
Year selected
2007
Website

Company Snapshot

Christopher founded Batswadi Pharmaceuticals in October 2005 as a specialist healthcare company focusing on four core business areas: pharmaceuticals, diagnostics, research and development, and consumer health. After jump-starting the company by leading a management buy-out of Eli Lilly’s insulin portfolio in South Africa, Christopher has quickly built Batswadi into a diversified company with significant potential. As the only black-empowered (majority-owned by historically disadvantaged South Africans) pharmaceutical company in South Africa, Batswadi is a rising star.

Endeavor and Batswadi Pharmaceuticals

Christopher is actively receiving guidance in the areas of fundraising and branding. In addition to local support, he has benefited from the Global eMBA and G-Lab programs, and an Immersion Tour.

Christopher has been on the Endeavor South Africa board since 2008, and serves as a local panelist.

From the Entrepreneurship Blog

Events

42 High-Impact Entrepreneurs from 12 Countries Join the Endeavor Network at the 55th International Selection Panel in Istanbul

October 24th, 2014 — by admin

Istanbul, Turkey – October 24, 2014 – At the 55th Endeavor International Selection Panel (ISP), 42 high-impact entrepreneurs leading 23 companies from 12 countries were welcomed into the Endeavor ne…

Read more

In the news

42 High-Impact Entrepreneurs from 12 Countries Join the Endeavor Network at the 55th International Selection Panel in Istanbul

October 24th, 2014 — by admin

Istanbul, Turkey – October 24, 2014 – At the 55th Endeavor International Selection Panel (ISP), 42 high-impact entrepreneurs leading 23 companies from 12 countries were welcomed into the Endeavor ne…

Read more

Contact us

Press center

Community

Newsletter Sign Up